Abstract:Abstract Background Ectopic pregnancy is a major life- and fertility-threatening women’s health concern. As a result of advances in examination technology, an increasing number of ectopic pregnancies can be diagnosed early and treated with medical methods instead of surgery. The aim of this study was to summarize the clinical features and identify the predictors of success of methotrexate (MTX) treatment of ectopic pregnancy. Methods This was a retrospective study of 238 ectopic pregnancies treated with MTX in the Department of Gynecology of Shaanxi Provincial People’s Hospital from January 2017 to December 2017. Results Patients were divided into two groups: the successful treatment group ( n = 166) and the failed treatment group ( n = 72). The overall success rate of MTX therapy for ectopic pregnancy was 69.75%. The mean initial beta-human chorionic gonadotropin (β-hCG) level was significantly lower in the successful treatment group than in the failed treatment group (2538.08 IU/L versus 3533.17 IU/L, P = 0.000). The treatment success rate of the group with an initial β-hCG concentration less than 4000 IU/L was significantly higher than that of the group with an initial β-hCG concentration greater than 4000 IU/L. However, the success rate of the group with an initial β-hCG concentration greater than 4000 IU/L was still relatively high (54.55%). β-hCG levels were significantly increased on the 4th day in the failed treatment group ( P = 0.000). Compared to the initial β-hCG level, the day-4 β-hCG level increased by more than 8.21%, indicating that the treatment was effective. The diagnostic sensitivity was 88.6%, the specificity was 74.5%, and the area under the receiver operating characteristic (ROC) curve was 0.863 (95% confidence interval (CI): 0.805–0.920). Conclusions MTX therapy as a treatment option is safe and effective for asymptomatic, hemodynamically stable patients with ectopic pregnancies who are interested in conservative treatment, regardless of the serum β-hCG level or adnexal mass size. The change in the β-hCG level between the initial day and the 4th day is an effective and early predictive tool for the success of MTX therapy for ectopic pregnancy.

The Relation Between Β-Hcg Changing Patterns and Ectopic Pregnancy Drug Therapy Protocol

The Value of Serum Β-Hcg, Progesterone and Ultrasound Examination in Monitoring Medical Therapy of Ectopic Pregnancy

Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy

Clinical Analysis of 49 Cases with Ectopic Pregnancy Treating by Chinese Traditional Medicine and Western Conservative Treatment

Clinical evaluation of conservative treatment for ectopic pregnancy

Evaluation of serum β-human chorionic gonadotropin and progesterone monitoring in medicinal conservative treatment for ectopic pregnancy

Clinical study on methotrexate with mifepristone in the treatment of ectopic pregnancy for 60 cases

Clinical Utility of Serum Reproductive Hormones for the Early Diagnosis of Ectopic Pregnancy in the First Trimester.

Evaluation of the parameters in predicting single‐dose methotrexate therapy success for ectopic pregnancy

Treatment of Ectopic Pregnancy by Two Dosages of Mifepristoned Plus Methotrexate

Clinical Observation on Therapeutic Effect of Transvaginal Ultrasound Interventional Treatment for Ectopic Pregnancy

Research on β-hCG and P Levels of Ectopic Pregnancy by Different Surgical Treatments

[Evolution of beta-hCG titers after systemic treatment of unruptured ectopic pregnancy]

Management of Ectopic Pregnancy by Intramuscular Injection of High Dose of Methotrexate

Clinical Observation of 66 Patients with Ectopic Pregnancy Treated by Combination of Traditional Chinese with Western Medicine

The curative effect of methotrexate combined with mifepristone in the treatment of 97 cases of tubal pregnancy

Daily variations and levels of human chorionic gonadotropin before methotrexate treatment as predictors of treatment success

Clinical Study of the Efficacy Therapy for Persistent Ectopic Pregnancy

The Applications of Transvaginal Sonography and Blood β-HCG Detection in the Medical Treatment of Tubal Ecotopic Pregnancy

Unusual Ectopic Pregnancy Treated with Transvaginal Ultrasound- Guided Fetal Reduction

Successful Conservative Management with Methotrexate and Mifepristone of Cervical Pregnancy